Meeting
2019 Gastrointestinal Cancers Symposium
A network meta-analysis of adjuvant systemic therapy in resected pancreatic cancer.
Authors
Jorge Chaves Porras
Sunnybrook. Health Sciences Centre, Toronto, ON, Canada
Jorge Chaves Porras , Kaitlyn Perry , Amanda Putri Rahmadian , Seanthel Delos Santos , Yoo-Joung Ko , Scott R. Berry , Mark Doherty , Kelvin K. Chan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 396)
DOI
10.1200/JCO.2019.37.4_suppl.396
Abstract #
396
Poster Bd #
L16
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
A network meta-analysis (NMA) of randomized controlled trials (RCT) of chemotherapy regimens for metastatic pancreatic cancer (mPC).
First Author: Gillian Gresham
Poster
2013 ASCO Annual Meeting
A Bayesian network meta-analysis of systemic regimens for advanced pancreatic cancer.
First Author: Kelvin K. Chan
Poster
2012 Gastrointestinal Cancers Symposium
Meta-analysis of randomized phase II and phase III trials of gemcitabine with/without S-1 in Asian patients with advanced pancreatic cancer.
First Author: Geoffrey Yuyat Ku
Poster
2021 ASCO Quality Care Symposium
Trends in use of one, two, and three-line NCCN category 1 regimens among Medicare fee-for-service (FFS) patients receiving treatment for metastatic pancreatic cancer.
First Author: Gabriela Dieguez